Method for culturing hair follicle-derived stem cells, and use thereof

US2025066725A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025066725-A1
Application numberUS-202218723596-A
CountryUS
Kind codeA1
Filing dateDec 23, 2022
Priority dateDec 24, 2021
Publication dateFeb 27, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method for culturing hair follicle-derived stem cells and uses thereof, particularly to a method for culturing hair follicle-derived stem cells; hair follicle-derived stem cells prepared by the method; and a pharmaceutical composition for hair loss treatment or hair growth promotion; a quasi-drug composition; and a cosmetic composition, which contains the prepared hair follicle-derived stem cells, a culture of the hair follicle-derived stem cells, or cells differentiated from the hair follicle-derived stem cells as an active ingredient.According to the culture method of the present invention, stem cells can be effectively isolated and obtained from hair follicle tissue, and the obtained hair follicle-derived stem cells have excellent pluripotency and self-replication ability as well as excellent hair loss treatment and hair growth promotion effects and can be usefully utilized for hair loss improvement, prevention, or treatment.

First claim

Opening claim text (preview).

1 . A method for culturing hair follicle-derived stem cells, the method comprising: (a) encapsulating a hair follicle tissue in a hydrogel and culturing the hair follicle tissue to obtain a culture; and (b) decomposing the hydrogel in the obtained culture to recover stem cells that have migrated from the hair follicle tissue into the hydrogel and proliferated in the hydrogel. 2 . The method for culturing hair follicle-derived stem cells according to claim 1 , wherein step (a) involves encapsulating a hair follicle tissue in a double-layered hydrogel and culturing the hair follicle tissue. 3 . The method for culturing hair follicle-derived stem cells according to claim 1 , wherein a fragment obtained by removing a site corresponding to follicular infundibulum from epidermis is used as the hair follicle tissue. 4 . The method for culturing hair follicle-derived stem cells according to claim 1 , wherein the hair follicle tissue is cultured for 3 to 20 days in step (a). 5 . The method for culturing hair follicle-derived stem cells according to claim 1 , wherein a hair follicle tissue is seeded with an inter-tissue spacing of 1 mm or more and 50 mm or less for hair follicle tissue culture in step (a). 6 . The method for culturing hair follicle-derived stem cells according to claim 1 , wherein the hair follicle-derived stem cells have increased expression of one or more genes selected from SANP25, COL10A1, TMEM119, AQP1, PLCB4, or ITGA8. 7 . The method for culturing hair follicle-derived stem cells according to claim 1 , wherein the hair follicle-derived stem cells have immunological characteristics in which CD73, CD90, CD105, Nestin, and Lgr5 are expressed but CD34, CD45, and HLA-DR are not expressed. 8 . Hair follicle-derived stem cells prepared by the method according to claim 1 . 9 . The hair follicle-derived stem cells according to claim 8 , which have increased expression of one or more genes selected from SANP25, COL10A1, TMEM119, AQP1, PLCB4, or ITGA8. 10 . The hair follicle-derived stem cells according to claim 8 , which have immunological characteristics in which CD73, CD90, CD105, Nestin, and Lgr5 are expressed but CD34, CD45, and HLA-DR are not expressed. 11 . A pharmaceutical composition for hair loss treatment or hair growth promotion, comprising hair follicle-derived stem cells prepared by the method according to claim 1 , a culture of the hair follicle-derived stem cells, or cells differentiated from the hair follicle-derived stem cells as an active ingredient. 12 . A quasi-drug composition for hair loss improvement or hair growth promotion, comprising hair follicle-derived stem cells prepared by the method according to claim 1 , a culture of the hair follicle-derived stem cells, or cells differentiated from the hair follicle-derived stem cells as an active ingredient. 13 . A cosmetic composition for hair loss improvement or hair growth promotion, comprising hair follicle-derived stem cells prepared by the method according to claim 1 , a culture of the hair follicle-derived stem cells, or cells differentiated from the hair follicle-derived stem cells as an active ingredient.

Assignees

Inventors

Classifications

  • from hair cells · CPC title

  • Cell encapsulation · CPC title

  • Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39) · CPC title

  • for baldness or alopecia · CPC title

  • 3D culture · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025066725A1 cover?
The present invention relates to a method for culturing hair follicle-derived stem cells and uses thereof, particularly to a method for culturing hair follicle-derived stem cells; hair follicle-derived stem cells prepared by the method; and a pharmaceutical composition for hair loss treatment or hair growth promotion; a quasi-drug composition; and a cosmetic composition, which contains the prep…
Who is the assignee on this patent?
Univ Ewha Ind Collaboration, Hierabio Inc
What technology area does this patent fall under?
Primary CPC classification A61Q7/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Feb 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).